Prosthetic Replacement of the Scaphoid Proximal Pole: Should It Be the Future?


Journal

Hand (New York, N.Y.)
ISSN: 1558-9455
Titre abrégé: Hand (N Y)
Pays: United States
ID NLM: 101264149

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 23 12 2020
medline: 1 9 2022
entrez: 22 12 2020
Statut: ppublish

Résumé

Scaphoid proximal pole fractures with avascular necrosis represent a complex surgical problem. Many reconstruction techniques are based on osteosynthesis with a vascularized or nonvascularized bone graft. These procedures do not allow early mobilization and therefore sometimes lead to unsatisfying functional results. In some cases, it is possible to perform a scaphoid hemiarthroplasty using a pyrocarbon implant (adaptive proximal scaphoid implant [APSI]) in place of the necrotic proximal pole, allowing an early mobilization and delaying palliative treatments such as 4-corner arthrodesis or proximal row carpectomy. In this study, we reviewed all patients who had undergone a scaphoid hemiarthroplasty using APSI in our institutions from 1999 to 2017; the F.U. was performed through radiographic, clinical, and subjective (Disabilities of the Arm, Shoulder, and Hand) analysis. The performances of scaphoid proximal pole implants are encouraging; radiographic, clinical, and subjective outcomes were good, and the functional recovery proved to be fast and reliable over time. This study reports our experience in the use of APSI implants, which proved to be a good alternative to traditional techniques for treating avascular necrosis of the proximal pole, still allowing further surgical steps in case of clinical worsening over time (wrist osteoarthritis). These patients are usually young and present high functional demands. Our experience is promising, but we believe that further evaluation over time will be needed.

Sections du résumé

BACKGROUND
Scaphoid proximal pole fractures with avascular necrosis represent a complex surgical problem. Many reconstruction techniques are based on osteosynthesis with a vascularized or nonvascularized bone graft. These procedures do not allow early mobilization and therefore sometimes lead to unsatisfying functional results. In some cases, it is possible to perform a scaphoid hemiarthroplasty using a pyrocarbon implant (adaptive proximal scaphoid implant [APSI]) in place of the necrotic proximal pole, allowing an early mobilization and delaying palliative treatments such as 4-corner arthrodesis or proximal row carpectomy.
METHODS
In this study, we reviewed all patients who had undergone a scaphoid hemiarthroplasty using APSI in our institutions from 1999 to 2017; the F.U. was performed through radiographic, clinical, and subjective (Disabilities of the Arm, Shoulder, and Hand) analysis.
RESULTS
The performances of scaphoid proximal pole implants are encouraging; radiographic, clinical, and subjective outcomes were good, and the functional recovery proved to be fast and reliable over time.
CONCLUSIONS
This study reports our experience in the use of APSI implants, which proved to be a good alternative to traditional techniques for treating avascular necrosis of the proximal pole, still allowing further surgical steps in case of clinical worsening over time (wrist osteoarthritis). These patients are usually young and present high functional demands. Our experience is promising, but we believe that further evaluation over time will be needed.

Identifiants

pubmed: 33349033
doi: 10.1177/1558944720974120
pmc: PMC9465777
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-904

Références

J Wrist Surg. 2019 Aug;8(4):344-350
pubmed: 31402997
J Wrist Surg. 2012 Nov;1(2):159-64
pubmed: 24179721
Rev Bras Ortop. 2018 Aug 02;53(5):582-588
pubmed: 30245998
J Foot Ankle Surg. 1993 Sep-Oct;32(5):490-8
pubmed: 8252007
Chir Main. 2000 Nov;19(5):276-85
pubmed: 11147202
Hand (N Y). 2011 Jun;6(2):179-84
pubmed: 22654701

Auteurs

Matteo Ferrero (M)

CTO Hospital, Torino, Italy.

Enrico Carità (E)

Clinica San Francesco, Verona, Italy.

Francesco Giacalone (F)

CTO Hospital, Torino, Italy.

Julien Teodori (J)

Università degli Studi di Perugia, Italy.

Alberto Donadelli (A)

Clinica San Francesco, Verona, Italy.

Mara Laterza (M)

Clinica San Francesco, Verona, Italy.

Massimo Corain (M)

Azienda Ospedaliera Universitaria Integrata Verona, Italy.

Bruno Battiston (B)

CTO Hospital, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH